ID24827A - Metoda peningkatan volume tulang dengan menggunakan agonis fp selektif yang terjadi secara non-alami - Google Patents

Metoda peningkatan volume tulang dengan menggunakan agonis fp selektif yang terjadi secara non-alami

Info

Publication number
ID24827A
ID24827A IDW20000637A ID20000637A ID24827A ID 24827 A ID24827 A ID 24827A ID W20000637 A IDW20000637 A ID W20000637A ID 20000637 A ID20000637 A ID 20000637A ID 24827 A ID24827 A ID 24827A
Authority
ID
Indonesia
Prior art keywords
agonists
improvement method
bone volume
volume improvement
natural selective
Prior art date
Application number
IDW20000637A
Other languages
English (en)
Indonesian (id)
Inventor
James Richard Hartke
Mark Walden Lundy
Mitchell Anthony Delong
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of ID24827A publication Critical patent/ID24827A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IDW20000637A 1997-09-09 1998-09-04 Metoda peningkatan volume tulang dengan menggunakan agonis fp selektif yang terjadi secara non-alami ID24827A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5830697P 1997-09-09 1997-09-09

Publications (1)

Publication Number Publication Date
ID24827A true ID24827A (id) 2000-08-24

Family

ID=22015996

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20000637A ID24827A (id) 1997-09-09 1998-09-04 Metoda peningkatan volume tulang dengan menggunakan agonis fp selektif yang terjadi secara non-alami

Country Status (20)

Country Link
US (1) US6156799A (no)
EP (1) EP1045694A1 (no)
JP (1) JP2001515864A (no)
KR (1) KR20010023840A (no)
CN (1) CN1269721A (no)
AR (1) AR013479A1 (no)
AU (1) AU739275B2 (no)
BR (1) BR9811780A (no)
CA (1) CA2303800A1 (no)
CO (1) CO4980882A1 (no)
HU (1) HUP0004581A2 (no)
ID (1) ID24827A (no)
IL (1) IL134760A0 (no)
NO (1) NO20001171L (no)
PE (1) PE119099A1 (no)
PL (1) PL339288A1 (no)
SK (1) SK3412000A3 (no)
TR (1) TR200000662T2 (no)
WO (1) WO1999012551A1 (no)
ZA (1) ZA988228B (no)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3385900A (en) * 1999-03-05 2000-09-21 Procter & Gamble Company, The Method of increasing bone volume using non-naturally-occurring selective fp agonist and dito ep1 agonist prostaglandin derivatives
ATE283256T1 (de) * 1999-03-05 2004-12-15 Univ Duke C-16 ungesätigte fp-selektive prostaglandin analoge
IL145128A0 (en) * 1999-03-05 2002-06-30 Procter & Gamble Method of increasing bone volume using non-naturally-occurring ep1 selective agonists
CA2364948C (en) * 1999-03-05 2011-04-26 Duke University C16 unsaturated fp-selective prostaglandins analogs
CA2303060A1 (en) * 1999-04-14 2000-10-14 United States Gear Corporation Towed vehicle brake controller
US6894175B1 (en) 1999-08-04 2005-05-17 The Procter & Gamble Company 2-Decarboxy-2-phosphinico prostaglandin derivatives and methods for their preparation and use
US20020037914A1 (en) 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US7545964B2 (en) 2000-08-29 2009-06-09 Imaging Therapeutics, Inc. Methods and devices for quantitative analysis of x-ray images
US6904123B2 (en) 2000-08-29 2005-06-07 Imaging Therapeutics, Inc. Methods and devices for quantitative analysis of x-ray images
US7467892B2 (en) 2000-08-29 2008-12-23 Imaging Therapeutics, Inc. Calibration devices and methods of use thereof
US7660453B2 (en) 2000-10-11 2010-02-09 Imaging Therapeutics, Inc. Methods and devices for analysis of x-ray images
US8639009B2 (en) 2000-10-11 2014-01-28 Imatx, Inc. Methods and devices for evaluating and treating a bone condition based on x-ray image analysis
DE60233485D1 (de) 2001-05-25 2009-10-08 Imaging Therapeutics Inc Verfahren zur diagnose, behandlung und prävention von knochenverlust
CN1893977B (zh) * 2001-07-23 2012-12-05 小野药品工业株式会社 以ep4激动剂为活性成分的治疗与骨质损失有关的疾病的药物
CN101921220B (zh) 2001-07-23 2013-05-22 小野药品工业株式会社 治疗与骨质损失有关的疾病的含有ep4激动剂作为活性成分的药物组合物
JP2006501138A (ja) * 2002-02-07 2006-01-12 ラットガーズ，ザ・ステート・ユニバーシティ・オブ・ニュージャージー ドラッグデリバリーのための治療用ポリ無水物化合物
US8600124B2 (en) 2004-09-16 2013-12-03 Imatx, Inc. System and method of predicting future fractures
US7840247B2 (en) 2002-09-16 2010-11-23 Imatx, Inc. Methods of predicting musculoskeletal disease
US8965075B2 (en) 2002-09-16 2015-02-24 Imatx, Inc. System and method for predicting future fractures
WO2004086972A2 (en) 2003-03-25 2004-10-14 Imaging Therapeutics, Inc. Methods for the compensation of imaging technique in the processing of radiographic images
US8290564B2 (en) 2003-09-19 2012-10-16 Imatx, Inc. Method for bone structure prognosis and simulated bone remodeling
US20080058613A1 (en) * 2003-09-19 2008-03-06 Imaging Therapeutics, Inc. Method and System for Providing Fracture/No Fracture Classification
EP1663002A4 (en) * 2003-09-19 2007-11-28 Imaging Therapeutics Inc METHOD FOR BONE STRUCTURE FORECAST AND SIMULATED BONE REFORMALIZATION
US8939917B2 (en) 2009-02-13 2015-01-27 Imatx, Inc. Methods and devices for quantitative analysis of bone and cartilage

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4621100A (en) * 1981-09-25 1986-11-04 The Upjohn Company Treatment of osteoporosis with prostaglandins
WO1993015767A1 (en) * 1992-02-05 1993-08-19 Merck & Co., Inc. Implant therapy for bone growth stimulation
US5310759A (en) * 1992-08-12 1994-05-10 Bockman Richard S Methods of protecting and preserving connective and support tissues
US5409911A (en) * 1992-09-11 1995-04-25 Merck & Co., Inc. Prostaglandin analog for treating osteoporosis
US5747660A (en) * 1995-11-06 1998-05-05 The University Of Colorado Nucleic acid encoding prostaglandin F2α receptor regulatory protein
US5703108A (en) * 1996-02-28 1997-12-30 Pfizer Inc. Bone deposition by certain prostaglandin agonists

Also Published As

Publication number Publication date
US6156799A (en) 2000-12-05
AR013479A1 (es) 2000-12-27
ZA988228B (en) 1999-03-09
HUP0004581A2 (hu) 2001-05-28
PE119099A1 (es) 2000-02-03
SK3412000A3 (en) 2000-12-11
CA2303800A1 (en) 1999-03-18
NO20001171D0 (no) 2000-03-07
BR9811780A (pt) 2000-09-12
TR200000662T2 (tr) 2000-07-21
JP2001515864A (ja) 2001-09-25
WO1999012551A1 (en) 1999-03-18
KR20010023840A (ko) 2001-03-26
PL339288A1 (en) 2000-12-04
CO4980882A1 (es) 2000-11-27
AU9219298A (en) 1999-03-29
AU739275B2 (en) 2001-10-11
EP1045694A1 (en) 2000-10-25
IL134760A0 (en) 2001-04-30
NO20001171L (no) 2000-05-09
CN1269721A (zh) 2000-10-11

Similar Documents

Publication Publication Date Title
PL339288A1 (en) Method of increasing bone volume using selective fp agonists not appearing in natural manner
ATE215369T1 (de) Carbazolanaloge als selektive beta3-adrenergische agonisten
DE59710667D1 (de) Knochenfräser
SG120070A1 (en) File operating method
DE69522843D1 (de) Knochenanker
DE69739924D1 (de) Zahnimplantatsystem
MXPA01002240A (es) Tratamiento selectvio de receptores de somatostatina endoteliales.
DE69715264D1 (de) Knochenprothese
DE69826451D1 (de) Anästehischer knochenzement
BR9703145A (pt) Diglicolatos de polialquileno absorvíveis
DE59707522D1 (de) Biocid ausgerüstetes, faserverstärktes schwammtuch
GB9828642D0 (en) Process slaughtering fish
EP1121147A4 (en) BIOLOGICALLY ACTIVE MUCOSAL ADJUVANTS SUBSTANTIALLY NON-TOXIC IN VERTEBRATES
DE69914264D1 (de) Knochenregenerierungsmaterial
DE69709501D1 (de) Kollagenmischung
FI981338L (fi) Menetelmä multikomponentti-alfa-interferonin valmistamiseksi
ID24759A (id) Metoda untuk meningkatkan volume tulang
FR2720419B1 (fr) Bloc artificiel.
ATE293931T1 (de) Implantsystem
DE69702125D1 (de) Implantat zum einzementieren in knochen
GB9928097D0 (en) Artificial fire apparatus
EP1042004A4 (en) METHOD FOR TISSUE PERFUSION
DK199900226U1 (da) Apparat til udtrækning af fiskeben
PL313987A1 (en) Fluoxetin obtained method
NO964545D0 (no) Benprotese